1. Home
  2. Live Updates
  3. Myelofibrosis patients with suboptimal response

Page 14 - Myelofibrosis Patients With Suboptimal Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Myelofibrosis patients with suboptimal response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Myelofibrosis Patients With Suboptimal Response Today - Breaking & Trending Today

Using JAK Inhibitors for Myelofibrosis

"We are thankfully starting to be blessed with more options than we ve ever had," but "in the frontline proliferative setting, ruxolitinib has remained the standard of care." ....

Anthonym Hunter , Emory University , Drug Administration , Society Of Hematologic Oncology , Properly Using , Hematologic Oncology , Platelet Count , Latelet Count Plt , Hrombocyte Count , Myelodysplastic Syndrome , Wernicke Encephalopathy , Wernickes Encephalopathy , Transplantation Stem Cell , Ransplantation Hematopoietic Stem Cell , Hematopoietic Stem Cell Transplantation , Stem Cell Transplantation , Stem Cell Therapy ,

GSK regulatory submission for myelofibrosis medicine momelotinib accepted for review by Japanese regulator

London: GSK plc has announced that the Ministry of Health, Labour and Welfare (MHLW), Japan, has accepted for review a new drug application (NDA) for momelotinib, a potential new medicine with a. ....

United States , City Of , United Kingdom , American Society Of Clinical Oncology , Ministry Of Health , Clinical Oncology , Annual Meeting , Gsk News ,

Research Nurse Breaks Down Myelofibrosis-Related Anemia

Myelofibrosis-related anemia is different than anemia experienced by patients without a cancer diagnosis, a research nurse explained. ....

Myeloproliferative Neoplasms ,

Survival Outcomes May Be Impacted By Socio-Racial Factors in Primary Myelofibrosis

A retrospective analysis of the Surveillance, Epidemiology, and End Results database emphasized the potential impact of specific socio-racial factors, such as race, sex, and age, on survival outcomes in patients with primary myelofibrosis. ....

Mohammad Bakri Hammami , Albert Einstein College Of Medicine , Jacobi Medical Center , Montefiore Medical Center , End Results , Albert Einstein College , Montefiore Medical , Pacific Islands , Society Of Hematologic Oncology Annual Meeting Soho , Myeloproliferative Neoplasms ,

Prognostic Model Could Help Predict Survival Outcomes for Patients With Myelofibrosis Undergoing AlloHCT

A predictive system developed using data from United States and European stem cell transplant registries was prognostic of survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation. ....

Memorial Sloan Kettering Cancer Center , New York , United States , Roni Tamari , International Blood , Dynamic International Prognostic Scoring System , Marrow Transplant Research , European Bone Marrow Transplant , Allogeneic Hematopoietic Cell Transplantation , Blood Advances ,